CLPP Protein

📖 Wiki Page

protein1228 wordssynced 2026-04-02

CLPP Protein

<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">CLPP Protein — Caseinolytic Mitochondrial Matrix Peptidase Proteolytic Subunit</th>
</tr>
<tr> [@jackson2015]
<td class="label">Protein Name</td>
<td>Caseinolytic mitochondrial matrix peptidase proteolytic subunit</td>
</tr>
<tr>
<td class="label">Gene</td>
<td>[CLPP](/genes/clpp)</td>
</tr>
<tr>
<td class="label">UniProt</td>
<td><a href="https://www.uniprot.org/uniprot/Q96EY8" target="_blank">Q96EY8</a></td>
</tr>
<tr>
<td class="label">Molecular Weight</td>
<td>23.4 kDa (monomer)</td>
</tr>
<tr>
<td class="label">Length</td>
<td>206 amino acids</td>
</tr>
<tr>
<td class="label">Subcellular Localization</td>
<td>Mitochondrial matrix</td>
</tr>
<tr>
<td class="label">Protein Family</td>
<td>CLP protease family (RecA-like ATPase superfamily)</td>
</tr>
<tr>
<td class="label">Enzyme Classification</td>
<td>Serine peptidase (EC 3.4.21.92)</td>
</tr>
<tr>
<td class="label">Brain Expression</td>
<td>[Hippocampus](/brain-regions/hippocampus), [Cortex](/brain-regions/cortex), Cerebellum, Dorsal root ganglia, Inner ear</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/als" style="color:#ef9a9a">ALS</a>, <a href="/wiki/aging" style="color:#ef9a9a">Aging</a>, <a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/ataxia" style="color:#ef9a9a">Ataxia</a>, <a href="/wiki/ftd" style="color:#ef9a9a">Ftd</a></td>
</tr>
<tr>

...

CLPP Protein

CLPP Protein — Caseinolytic Mitochondrial Matrix Peptidase Proteolytic Subunit

Introduction

Clpp Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

Overview

CLPP (Caseinolytic Mitochondrial Matrix Peptidase Proteolytic Subunit) is a key component of the mitochondrial CLPXP protease complex, which plays essential roles in mitochondrial protein quality control, metabolic regulation, and cellular homeostasis.[@gispert2013] CLPP is highly conserved from bacteria to humans and is essential for normal mitochondrial function. Mutations in CLPP cause Perrault syndrome (sensorineural hearing loss with ovarian insufficiency) and have been linked to various neurodegenerative diseases.[@szczepanowska2016]

Protein Structure

Domain Architecture

CLPP forms a hexameric ring structure composed of six identical subunits:

N-terminal domain: Involved in substrate recognition and hexamer assembly
Catalytic serine protease domain: Contains the active site serine (Ser98) and catalytic triad
RecA-like ATPase domain: Present in the related CLPXP ATPase component (CLPX)

The hexameric structure creates a central chamber where proteolysis occurs, with substrate entry controlled by the ATPase component.[@kang2005]

Oligomeric States

Active form: Hexameric ring (12 subunits total - two stacked rings)
Dimerization interface: Critical for protease activity
Assembly factors: CLPX (ATPase) facilitates substrate delivery

Normal Cellular Functions

Mitochondrial Protein Quality Control

CLPP is the proteolytic core of the CLPXP complex:

Recognition: CLPX recognizes misfolded or damaged proteins via degron sequences
Unfolding: CLPX uses ATP to unfold substrates and translocate them into CLPP
Degradation: CLPP cleaves substrates into peptides for mitochondrial recycling

Key substrates include:

Mitochondrial translation products
Oxidatively damaged proteins
Misfolded membrane proteins
Import intermediates

Mitochondrial Gene Expression

CLPP processes mitochondrial-encoded proteins:

tRNA processing: Involved in mitochondrial tRNA maturation
rRNA assembly: Participates in ribosomal protein assembly
Translation regulation: Modulates mitochondrial translation rates

Cellular Stress Response

CLPP participates in multiple stress response pathways:

Oxidative stress: Degrades oxidatively damaged mitochondrial proteins
Heat shock response: Part of the mitochondrial [unfolded protein response](/entities/unfolded-protein-response) (mtUPR)
Inflammation: Regulates inflammatory signaling via mitochondrial DNA release

Role in Neurodegenerative Diseases

Alzheimer's Disease (AD)

CLPP has several connections to AD pathogenesis:

Mitochondrial Dysfunction:

CLPP activity declines with age and in AD brains
Accumulation of damaged mitochondrial proteins in AD is partially due to reduced CLPP function[@sborgi2016]
Amyloid-β accumulation in mitochondria impairs CLPP function

Inflammation:

CLPP deficiency triggers mitochondrial inflammation
[NLRP3 inflammasome](/entities/nlrp3-inflammasome) activation in CLPP-deficient cells
Therapeutic potential of CLPP activators in AD

Metabolic Dysfunction:

CLPP regulates mitochondrial metabolic enzymes
Altered energy metabolism in AD involves CLPP dysfunction

Parkinson's Disease (PD)

CLPP is relevant to PD through mitochondrial pathways:

PINK1/Parkin Pathway:

CLPP interacts with PINK1/Parkin mitophagy pathway
Loss of CLPP impairs mitophagy efficiency
Mitochondrial quality control deficits in PD models

[α-Synuclein](/proteins/alpha-synuclein) Toxicity:

CLPP can degrade some α-synuclein species
Reduced CLPP activity enhances α-synuclein aggregation
Mitochondrial CLPP dysfunction in PD brain tissue

Dopaminergic Neuron Vulnerability:

Dorsal root ganglia and inner ear (where CLPP is highly expressed) show selective vulnerability
Similar to dopaminergic neuron vulnerability in PD

Amyotrophic Lateral Sclerosis (ALS)

CLPP connections to ALS:

Mitochondrial protein aggregates in ALS contain CLPP
[TDP-43](/mechanisms/tdp-43-proteinopathy) pathology intersects with mitochondrial quality control
CLPP dysfunction in ALS patient fibroblasts

Huntington's Disease (HD)

Emerging evidence links CLPP to HD:

Mitochondrial dysfunction in HD involves CLPP
Mutant [huntingtin](/proteins/huntingtin) affects mitochondrial protein quality control
CLPP activity modulation affects HD cellular phenotypes

Perrault Syndrome (PRLTS)

CLPP is causally linked to Perrault syndrome:

Biallelic loss-of-function mutations cause the disease
Sensorineural hearing loss (SNHL) due to hair cell degeneration
Ovarian dysfunction (premature ovarian failure)
Sometimes accompanied by neurological features including neuropathy[@jackson2015]

Therapeutic Implications

Small Molecule Modulators

CLPP Activators:

Novel small molecules being developed to enhance CLPP activity
Potential for treating mitochondrial proteostasis disorders
Could improve mitophagy in PD and related disorders

CLPP Inhibitors:

Used as research tools to study CLPP function
Potential applications in cancer therapy (some tumors depend on CLPP)
Not suitable for neurodegeneration treatment

Gene Therapy Approaches

Viral vector delivery to increase CLPP expression
CRISPR-based therapies for Perrault syndrome
Cell-type specific targeting considerations

Interaction Network

CLPP interacts with multiple proteins:

| Protein | Interaction Type | Functional Consequence |
|---------|-----------------|----------------------|
| CLPX | Complex formation | Substrate recognition and unfolding |
| LONP1 | Coordinated proteostasis | Overlapping substrate specificity |
| mitochondrial DNA polymerase γ | Substrate | mtDNA replication regulation |
| mitochondrial ribosomal proteins | Substrate | Translation quality control |
| HSL1 | Substrate | Cell cycle regulation |
| TFAM | Indirect | Mitochondrial transcription |

Research Methods

Detecting CLPP Activity

Protease assays: Using casein or fluorescent substrates
Proteomics: Identifying CLPP substrates
Blue-native PAGE: Detecting CLPXP complex formation

Animal Models

Clpp knockout mice: Viable but with sensory deficits
Conditional knockouts: Tissue-specific deletion models
Disease models: Crossbreeding with AD/PD models

Summary

CLPP is a critical mitochondrial protease essential for protein quality control and cellular homeostasis. Its dysfunction contributes to neurodegenerative diseases through impaired mitochondrial proteostasis, inflammation, and metabolic dysfunction. While CLPP mutations cause Perrault syndrome, reduced CLPP activity in aging and age-related diseases like AD and PD suggests therapeutic potential for CLPP-enhancing approaches. The development of small molecule CLPP activators represents a promising therapeutic strategy for neurodegenerative diseases with mitochondrial dysfunction.

Background

The study of Clpp Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

External Links

[PubMed](https://pubmed.ncbi.nlm.nih.gov/) - Biomedical literature
[Alzheimer's Disease Neuroimaging Initiative](https://adni.loni.usc.edu/) - Research data
[Allen Brain Atlas](https://brain-map.org/) - Brain gene expression data

References

[Gispert S, et al, CLPP deficiency causes sensory neuropathy and hearing loss (2013)](https://pubmed.ncbi.nlm.nih.gov/23575224/)

[Szczepanowska K, et al, CLPP coordinates mitochondrial proteostasis (2016)](https://pubmed.ncbi.nlm.nih.gov/26987945/)

[Kang SG, et al, Crystal structure of the proteolytic component of the mitochondrial CLPXP system (2005)](https://pubmed.ncbi.nlm.nih.gov/16287973/)

Sborgi L, et al, CLPP and neurodegeneration: emerging role of mitochondrial proteostasis (2016)

Unknown, The Jackson Laboratory. CLPP and Perrault syndrome (2015)

📖 View canonical wiki page →

CLPP Protein

CLPP Protein

CLPP Protein

CLPP Protein — Caseinolytic Mitochondrial Matrix Peptidase Proteolytic Subunit

Introduction

Overview

Protein Structure

Domain Architecture

Oligomeric States

Normal Cellular Functions

Mitochondrial Protein Quality Control

Mitochondrial Gene Expression

Cellular Stress Response

Role in Neurodegenerative Diseases

Alzheimer's Disease (AD)

Parkinson's Disease (PD)

Amyotrophic Lateral Sclerosis (ALS)

Huntington's Disease (HD)

Perrault Syndrome (PRLTS)

Therapeutic Implications

Small Molecule Modulators

Gene Therapy Approaches

Interaction Network

Research Methods

Detecting CLPP Activity

Animal Models

Summary

Background

External Links

See Also

References